ArticleJournal of pharmacy & bioallied sciences2024
Presence of Aspartate Aminotransferase in Peri-Implant Crevicular Fluid with and without Mucositis.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aspartate aminotransferase (AST) is an enzyme commonly found in various body fluids and tissues, including peri-implant crevicular fluid (PICF). Its presence and activity in PICF have been implicated in inflammatory conditions such as mucositis around dental implants. Materials and Methods: This study aimed to compare the levels of AST in PICF collected from sites with mucositis (group A) and healthy sites (group B). PICF samples were collected using standardized paper strips and analyzed using enzymatic assays. The AST levels were quantified using a spectrophotometric method, and the data were statistically analyzed using Student's Results: The mean AST level in group A (mucositis) was found to be 12.3 ± 2.1 U/mL, whereas in group B (healthy sites), it was significantly lower at 5.7 ± 1.3 U/mL ( Conclusion: Elevated levels of AST in PICF suggest its potential as a biomarker for detecting inflammatory conditions such as mucositis around dental implants. Monitoring AST levels in PICF could aid in the early detection and management of peri-implant diseases, contributing to improved clinical outcomes and implant longevity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.